Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR).
Tenenbaum A, Fisman EZ, Motro M
Cardiovasc Diabetol 2003 Mar 23, 2:4
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Update on the use of fibrates: focus on bezafibrate.
Goldenberg I, Benderly M, Goldbourt U
Vasc Health Risk Manag 2008, 4:131-41
[PubMed Central] [PubMed] [Related articles]

2.
P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S
Br J Pharmacol 2009 Jul, 157:724-35
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 9 articles in BioMed Central

printer friendly 
to  [Help]

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.